Equities on the Move – Research on GTX Inc, Juniper Pharmaceuticals, Catabasis Pharmaceuticals and Amber Road

NEW YORK, NY / ACCESSWIRE / December 1, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: GTX Inc (NASDAQ: GTXI), Juniper Pharmaceuticals Inc (NASDAQ: JNP), Catabasis Pharmaceuticals Inc (NASDAQ: CATB) and Amber Road Inc (NYSE: AMBR). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

GTXI Research Package: http://www.traders-choice.com/pdf?s=GTXI

JNP Research Package: http://www.traders-choice.com/pdf?s=JNP

CATB Research Package: http://www.traders-choice.com/pdf?s=CATB

AMBR Research Package: http://www.traders-choice.com/pdf?s=AMBR

============

Highlights from today’s reports include:

On Monday, November 30, 2015, Nasdaq ended at 5,108.67 down 0.37%, Dow Jones declined 0.44%, to finish the day at 17,719.92, and the S&P closed at 2,080.41, down 0.46%.

– The stock of GTX Inc lost 3.11% to close Monday’s session at USD 0.93. The shares of the company moved in the range of USD 0.92 and USD 0.99. A trading volume of 0.03 million shares was recorded, which was lower than its 150-day daily average volume, and its 52-week average volume of 0.15 million shares each. Over the last five days, GTX Inc’s shares have declined by 7.00% and in the past one month, the stock has lost 10.58%. However, over the last three months, the stock has advanced 1.31%, and year to date the shares have gained 27.40%. The company has returned 6.41% in the last three months, and 52.46% in the past one year on a compounded total return basis. The stock is at a price to book ratio of 31.25. The historical PB ratio is near to 5.75. GTX Inc’s shares have a market cap of USD 130.55 million.

– Juniper Pharmaceuticals Inc’s stock decreased by 3.27% to close Monday’s session at USD 11.84. The company’s shares fluctuated in the range of USD 11.83 and USD 12.46. A total of 0.05 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.06 million shares. Over the last three days Juniper Pharmaceuticals Inc’s shares have advanced 1.98% and in the past one week the stock has moved up 1.89%. Furthermore, over the last three months, the stock has gained 11.70% and in the past six months, the shares have picked up 36.88%. The company has returned 8.33% in the past three months, and 47.45% in the last half year, on a compounded total return basis. Further, the stock is trading 1.23% above its 20 day moving average and 13.91% above its 200 day moving average with a Relative Strength Index of 50.53.

– Catabasis Pharmaceuticals Inc’s stock added 5.87% to close Monday’s session at USD 8.30. The company’s shares oscillated between USD 8.00 and USD 8.40. The stock recorded a trading volume of 0.01 million shares, which was below its 50-day daily average volume of 0.04 million shares and below its 52-week average volume of 0.07 million shares. Over the last five days, Catabasis Pharmaceuticals Inc’s shares have advanced 14.17% and in the past one month, it has gained a momentum of 10.52%. However, over the last three months, the stock has lost 27.13%. The stock has returned 13.39% in the past one week, and 18.91% in the past one month, on a compounded total return basis. Moreover, the stock is trading 11.31% above its 20-day moving average and 6.37% above its 50-day moving average. Further, Catabasis Pharmaceuticals Inc’s shares have a market capitalization of USD 126.97 million.

– Amber Road Inc’s stock declined 2.24% to close Monday’s session at USD 4.81. The share price vacillated between USD 4.78 and USD 5.04. The stock recorded a trading volume of 0.09 million shares, which was below its 50-day daily average volume of 0.10 million shares and below its 52-week average volume of 0.11 million shares. Over the last three days Amber Road Inc’s shares have advanced 9.32% and in the past one week it has moved up 30.35%. However, in the last six months, the stock has lost 30.49% and year to date, the shares have shed 52.94%. The company’s shares are trading at a price to book (mrq) ratio of 2.57 and at a price to sales (ttm) ratio of 1.91. Further Amber Road Inc has an Enterprise value of USD 130.57 million. The stock is trading at a Relative Strength Index of 66.20.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 434217